Beatriz M. Carreno

20.3k citations

75 papers · 11.3k indexed · 4 hit papers · h-index 40

Immunology top 0.1%
- T-cell and B-cell Immunology 41
- Immunotherapy and Immune Responses 38
- Immune Cell Function and Interaction 34
- Immune Response and Inflammation 5
Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers 18
- CAR-T cell therapy research 17
Virology top 5%
Cancer Research top 5%
Pathology and Forensic Medicine top 2%
Molecular Biology
- vaccines and immunoinformatics approaches 15
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 15

Co-authors: Mary Collins Vincent Ling Laura Carter Lori Fitz Clive R. Wood Lynette A. Fouser Tasuku Honjo Hiroyuki Nishimura
Cited by: Immunology Oncology Virology
Partner nations: United States Canada Hungary

In The Last Decade

Beatriz M. Carreno

73 papers receiving 11.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
2002 PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2
2002 The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune Responses
2000 Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation

Peers

Countries citing papers authored by Beatriz M. Carreno

Since Specialization

Citations

This map shows the geographic impact of Beatriz M. Carreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz M. Carreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz M. Carreno more than expected).

Fields of papers citing papers by Beatriz M. Carreno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz M. Carreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz M. Carreno. The network helps show where Beatriz M. Carreno may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Beatriz M. Carreno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Beatriz M. Carreno Line = papers co-authored together Beatriz M. Carreno links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Facts and Hopes in Immunotherapy Strategies Targeting Antigens Derived from KRAS Mutations Gerald P. Linette,Adham S. Bear,Beatriz M. Carreno	2024	6
2	Natural TCRs targeting KRASG12V display fine specificity and sensitivity to human solid tumors Adham S. Bear,Rebecca B. Nadler,Mark H. O’Hara,Kelsey Stanton,Chong Xu,Robert Saporito,Andrew J. Rech,Miren L. Baroja,Tatiana Blanchard,Maxwell H Elliott,Michael Ford,Richard G. Jones,Shivang Patel,Andrea Brennan,Zachary O'Neil,Daniel J. Powell,Robert H. Vonderheide,Gerald P. Linette,Beatriz M. Carreno	2024	12
3	A genetically encoded protein tag for control and quantitative imaging of CAR T cell therapy Iris K. Lee,Nitika Sharma,Estela Noguera-Ortega,Maria Liousia,Miren L. Baroja,Jean M. Etersque,Jonathan Pham,Swarbhanu Sarkar,Beatriz M. Carreno,Gerald P. Linette,Ellen Puré,Steven Μ. Albelda,Mark A. Sellmyer	2023	7
4	Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting Adham S. Bear,Tatiana Blanchard,Joseph Cesare,Michael Ford,Lee P. Richman,Chong Xu,Miren L. Baroja,Sarah McCuaig,Christina Costeas,Khatuna Gabunia,John Scholler,Avery D. Posey,Mark H. O’Hara,Anže Smole,Daniel J. Powell,Benjamin A. García,Robert H. Vonderheide,Gerald P. Linette,Beatriz M. Carreno	2021	73
5	pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens Jasreet Hundal,Beatriz M. Carreno,Allegra A. Petti,Gerald P. Linette,Obi L. Griffith,Elaine R. Mardis,Malachi Griffith	2016	267
6	A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cellsbreakdown → Beatriz M. Carreno,Vincent Magrini,Michelle Becker‐Hapak,Saghar Kaabinejadian,Jasreet Hundal,Allegra A. Petti,Amy Ly,Wen‐Rong Lie,William H. Hildebrand,Elaine R. Mardis,Gerald P. Linette	2015	997
7	IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity Beatriz M. Carreno,Michelle Becker‐Hapak,Alexander C. Huang,M. Chan,Amer Alyasiry,Wen‐Rong Lie,Rebecca Aft,Lynn A. Cornelius,Kathryn Trinkaus,Gerald P. Linette	2013	135
8	Dendritic cell-based vaccines Gerald P. Linette,Beatriz M. Carreno	2013	13
9	Strain-Specific Variation in Murine Natural Killer Gene Complex Contributes to Differences in Immunosurveillance for Urethane-Induced Lung Cancer Daniel Kreisel,Andrew E. Gelman,Ryuji Higashikubo,Xue Lin,Haris G. Vikis,J. Michael White,Kelsey A. Toth,Charuhas Deshpande,Beatriz M. Carreno,Ming You,Samantha Taffner,Wayne M. Yokoyama,Jack D. Bui,Robert D. Schreiber,Alexander S. Krupnick	2012	22
10	The Human IL-17F/IL-17A Heterodimeric Cytokine Signals through the IL-17RA/IL-17RC Receptor Complex Jill F. Wright,Frann Bennett,Bilian Li,Jonathan Brooks,Deborah Luxenberg,Matthew J. Whitters,Kathleen Tomkinson,Lori Fitz,Neil M. Wolfman,Mary Collins,Kyri Dunussi‐Joannopoulos,Moitreyee Chatterjee‐Kishore,Beatriz M. Carreno	2008	238
11	Identification of an Interleukin 17F/17A Heterodimer in Activated Human CD4+ T Cells Jill F. Wright,Yongjing Guo,Amira Quazi,Deborah Luxenberg,Frann Bennett,John F. Ross,Yongchang Qiu,Matthew J. Whitters,Kathleen Tomkinson,Kyri Dunussi‐Joannopoulos,Beatriz M. Carreno,Mary Collins,Neil M. Wolfman	2007	255
12	Role of IL-17A, IL-17F, and the IL-17 Receptor in Regulating Growth-Related Oncogene-α and Granulocyte Colony-Stimulating Factor in Bronchial Epithelium: Implications for Airway Inflammation in Cystic Fibrosis Florencia McAllister,Adam C. Henry,James L. Kreindler,Patricia J. Dubin,Lauren Ulrich,Chad Steele,Jonathan D. Finder,Joseph M. Pilewski,Beatriz M. Carreno,Samuel J. Goldman,Jaana Pirhonen,Jay K. Kolls	2005	330
13	The B7 family of immune-regulatory ligands. Mary Collins,Vincent Ling,Beatriz M. Carreno	2005	258
14	Conversion of CTLA-4 from Inhibitor to Activator of T Cells with a Bispecific Tandem Single-Chain Fv Ligand Joaquı́n Madrenas,Luan A. Chau,Wendy A. Teft,Paul W. Wu,Jason Jussif,Marion T. Kasaian,Beatriz M. Carreno,Vincent Ling	2004	26
15	Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells Geoffrey L. Stephens,Rebecca S. McHugh,Matthew J. Whitters,Deborah Young,Deborah Luxenberg,Beatriz M. Carreno,Mary Collins,Ethan M. Shevach	2004	393
16	Blockade of Programmed Death-1 Engagement Accelerates Graft-Versus-Host Disease Lethality by an IFN-γ-Dependent Mechanism Bruce R. Blazar,Beatriz M. Carreno,Angela Panoskaltsis‐Mortari,Laura Carter,Yoshiko Iwai,Hideo Yagita∥,Hiroyuki Nishimura,Patricia A. Taylor	2003	267
17	Cytotoxic T-Lymphocyte Antigen-4 and Programmed Death-1 Function as Negative Regulators of Lymphocyte Activation Laura Carter,Beatriz M. Carreno	2003	28
18	Inhibition of CTLA-4 Function by the Regulatory Subunit of Serine/Threonine Phosphatase 2A Miren L. Baroja,Lalitha Vijayakrishnan,Estelle Bettelli,Peter J. Darlington,Thu Chau,Vincent Ling,Mary Collins,Beatriz M. Carreno,Joaquı́n Madrenas,Vijay K. Kuchroo	2002	76
19	CTLA-4 (CD152) Can Inhibit T Cell Activation by Two Different Mechanisms Depending on Its Level of Cell Surface Expression Beatriz M. Carreno,Frann Bennett,Thu Chau,Vincent Ling,Deborah Luxenberg,Jason Jussif,Miren L. Baroja,Joaquı́n Madrenas	2000	216
20	Residues in pockets B and F of HLA-B27 are critical in the presentation of an influenza A virus nucleoprotein peptide and influence the stability of peptide-MHC complexes Beatriz M. Carreno,Christine Winter,Joel D. Taurog,Ted H. Hansen,William E. Biddison	1993	24

About Beatriz M. Carreno

Beatriz M. Carreno is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 75 papers that have together received 11.3k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (41 papers), Immunotherapy and Immune Responses (38 papers), Immune Cell Function and Interaction (34 papers), Cancer Immunotherapy and Biomarkers (18 papers), CAR-T cell therapy research (17 papers), vaccines and immunoinformatics approaches (15 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and Immune Response and Inflammation (5 papers). The work is most often cited by research in Immunology (8.4k citations), Oncology (5.6k citations) and Virology (160 citations). Beatriz M. Carreno has collaborated with scholars based in United States, Canada and Hungary. Frequent co-authors include Mary Collins, Vincent Ling, Laura Carter, Lori Fitz, Clive R. Wood, Lynette A. Fouser, Tasuku Honjo, Hiroyuki Nishimura, Yoshiko Iwai and Heidi F. Horton.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact